Scans could help tailor pancreatic cancer treatment

February 12, 2018, Cancer Research UK
Scans could help tailor pancreatic cancer treatment
Credit: Cancer Research UK

Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to the National Institute for Health and Care Excellence (NICE).

New guidance from NICE says a PET-CT scan should be used early in the process of diagnosing pancreatic . It is thought that the scans will give doctors more on how advanced the disease is.

Professor Mark Baker, director of the centre for guidelines at NICE, said giving the PET-CT scan could have a significant impact on the treatment of patients with pancreatic cancer.

"It will mean that the staging process is more effective so that patients stand a better chance of getting the right treatment, at the right time," he said.

Deciding on treatment

Around 9,600 people in the UK are diagnosed with pancreatic cancer each year and survival is stubbornly low.

Surgery is most effective for patients if their disease has been diagnosed early.

NICE estimates that using the PET-CT scan to determine the stage of pancreatic cancer will reduce the number of NHS surgeries to remove these tumours by around 20%. This means that patients with more advanced pancreatic cancer will not undergo surgery that they are unlikely to benefit from.

This would help limit the side effects of surgery. And NICE said those who are not suitable for surgery will then be able to access chemotherapy treatment sooner.

It could also then free up theatre time for other patients.

Professor Andrew Biankin, Cancer Research UK's pancreatic cancer expert, approved of the new guidelines and said they were "an important step forward in making treatment selection for cancer patients more precise."

How does a PET-CT work?

A PET-CT scan is a type of imaging machine that combines a CT scan and a PET scan. It gives doctors detailed information about a person's cancer, including the size of the tumour and whether it has spread.

The CT scan takes a series of x-rays around the body and the PET scan uses a radioactive drug to highlight areas in the body where cells are more active than normal.

Biankin added that more research was needed to look at how to better personalise treatment.

"We now need to work on better ways to select the best for an individual, which will require testing and imaging at a molecular level," he said.

"At Cancer Research UK, our Flagship Programme PRECISION Panc, based in Glasgow, is working on ways to do just that.

"This programme aims to find the right clinical trial for the patient by offering cutting edge molecular testing of their cancer. The patient can then take part in a trial that's testing out new drugs that better match their individual tumour."

Explore further: A groundbreaking pancreatic cancer trial aims to match patients with more targeted and effective treatm

More information: Paula Ghaneh et al. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer, Health Technology Assessment (2018). DOI: 10.3310/hta22070

Related Stories

A groundbreaking pancreatic cancer trial aims to match patients with more targeted and effective treatm

December 5, 2017
A ground-breaking new pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, is to begin in Scotland.

New era in precision medicine for pancreatic cancer

March 23, 2017
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research ...

Narrowing the gap toward precision medicine for pancreatic cancer

January 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center's Jen Jen Yeh, MD, is working to understand the complicated relationship between one of the deadliest cancers and the web of connective tissue that can surround ...

Do pancreatic cysts become cancerous?

November 21, 2017
What is a pancreatic cyst?

Pancreatic cancer trial to make tumours more sensitive to treatment

August 30, 2016
Cancer Research UK (CRUK) launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy, with University of Glasgow researcher Professor Jeff Evans as ...

Scientists link pancreatic cancer survival to four genes

November 3, 2017
Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

Recommended for you

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

NEJM reports positive results for larotrectinib against TRK-fusion cancer

February 22, 2018
In 2013, the labs of University of Colorado Cancer Center investigator Robert C. Doebele, MD, PhD, and Dana-Farber Cancer Institute investigator Pasi A. Jänne, MD, PhD reported in Nature Medicine the presence of TRK gene ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.